SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-307465
Filing Date
2014-08-13
Accepted
2014-08-13 07:17:59
Documents
12
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d751141d10q.htm 10-Q 508300
2 EX-10.1 d751141dex101.htm EX-10.1 11174
3 EX-31.1 d751141dex311.htm EX-31.1 7975
4 EX-31.2 d751141dex312.htm EX-31.2 7971
5 EX-32.1 d751141dex321.htm EX-32.1 2925
6 EX-32.2 d751141dex322.htm EX-32.2 2935
  Complete submission text file 0001193125-14-307465.txt   6124111

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT petx-20140630.xml EX-101.INS 799503
8 XBRL TAXONOMY EXTENSION SCHEMA petx-20140630.xsd EX-101.SCH 68295
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE petx-20140630_cal.xml EX-101.CAL 101271
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE petx-20140630_def.xml EX-101.DEF 249969
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE petx-20140630_lab.xml EX-101.LAB 500547
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE petx-20140630_pre.xml EX-101.PRE 387830
Mailing Address 1901 OLATHE BOULEVARD KANSAS CITY KS 66103
Business Address 1901 OLATHE BOULEVARD KANSAS CITY KS 66103 913.951.2130
ARATANA THERAPEUTICS, INC. (Filer) CIK: 0001509190 (see all company filings)

IRS No.: 383826477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35952 | Film No.: 141035700
SIC: 2834 Pharmaceutical Preparations